Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mike Sathekge

Showing results (121-130 of 127) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 127 results.
European Journal of Nuclear Medicine and Molecular Imaging|May 9, 2020
Prior therapies as prognostic factors of overall survival in metastatic castration-resistant prostate cancer patients treated with [<sup>177</sup>Lu]Lu-PSMA-617. A WARMTH multicenter study (the 617 trial)Hojjat Ahmadzadehfar, Kambiz Rahbar, Richard P Baum, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 5, 2025
Exploring the feasibility of a 40-minute uptake time for long axial field of view [<sup>18</sup>F]FDG PET/CT tumour scan: an evidence-based single-center studyYibo He, Huaping Gao, Haojun Yu, et al.
Journal of Clinical Medicine|January 21, 2023
The SARS-COV-2 Seroprevalence among Oncology PatientsMankgopo Kgatle, Rajesh Das, Ismaheel Lawal, et al.
Journal of Cancer Policy|March 31, 2024
Six country vignettes: Strengthening radiotherapy and theranosticsMiriam Mikhail-Lette, Lisbeth Cordero, Yolande Lievens, et al.
European Urology|September 24, 2023
European Association of Nuclear Medicine Focus 5: Consensus on Molecular Imaging and Theranostics in Prostate CancerDaniela-Elena Oprea-Lager, Steven MacLennan, Anders Bjartell, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 7, 2024
Guiding principles on the education and practice of theranosticsThomas N B Pascual, Diana Paez, Andrei Iagaru, et al.
European Urology|July 3, 2026
Diagnosis and Staging of Patients with Prostate Cancer: Report from the 2025 Advanced Prostate Cancer Consensus Conference (APCCC) DiagnosticsStefano Fanti, Fabio Turco, Bertrand Tombal, et al.
Pageof 13

Showing results (121-130 of 127) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 127 results.
European Journal of Nuclear Medicine and Molecular Imaging|May 9, 2020
Prior therapies as prognostic factors of overall survival in metastatic castration-resistant prostate cancer patients treated with [<sup>177</sup>Lu]Lu-PSMA-617. A WARMTH multicenter study (the 617 trial)Hojjat Ahmadzadehfar, Kambiz Rahbar, Richard P Baum, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 5, 2025
Exploring the feasibility of a 40-minute uptake time for long axial field of view [<sup>18</sup>F]FDG PET/CT tumour scan: an evidence-based single-center studyYibo He, Huaping Gao, Haojun Yu, et al.
Journal of Clinical Medicine|January 21, 2023
The SARS-COV-2 Seroprevalence among Oncology PatientsMankgopo Kgatle, Rajesh Das, Ismaheel Lawal, et al.
Journal of Cancer Policy|March 31, 2024
Six country vignettes: Strengthening radiotherapy and theranosticsMiriam Mikhail-Lette, Lisbeth Cordero, Yolande Lievens, et al.
European Urology|September 24, 2023
European Association of Nuclear Medicine Focus 5: Consensus on Molecular Imaging and Theranostics in Prostate CancerDaniela-Elena Oprea-Lager, Steven MacLennan, Anders Bjartell, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 7, 2024
Guiding principles on the education and practice of theranosticsThomas N B Pascual, Diana Paez, Andrei Iagaru, et al.
European Urology|July 3, 2026
Diagnosis and Staging of Patients with Prostate Cancer: Report from the 2025 Advanced Prostate Cancer Consensus Conference (APCCC) DiagnosticsStefano Fanti, Fabio Turco, Bertrand Tombal, et al.
Pageof 13